Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $17M to Market Optical Mapping System

Premium

This story was originally published Sept. 27

OpGen, a commercial provider of optical restriction-mapping technology, has raised $17 million in Series B financing.

The financing adds to $23.6 million that the company raised in a Series A round in 2007 (IS 9/21/2007). The Series B was led by jVen Capital with participation from the company's other major investors, including CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical, and Versant Ventures. In addition, Evan Jones, the managing member of jVen Capital, has been named executive chairman of OpGen's board of directors.

OpGen's commercial optical mapping system, which was launched this June for microbial genome analysis, is an automated technology for generating maps that can be used in strain typing, comparative genomics, and sequence assembly.

The new funding will support marketing for the technology, dubbed the Argus Optical Mapping System. It will also "fuel our efforts to expand into new markets, including the development of new applications that will complement sequencing technologies and help facilitate rapid completion of large genome mapping and finishing technologies currently under development at the company," OpGen's CEO Douglas White said in a statement.

According to the company, the Argus system will have a wide range of applications in fields such as biodefense, outbreak management, agriculture, and clinical microbiology.

OpGen's customers include biodefense organizations, genomic research centers, academic institutions, clinical research organizations, and biotechnology companies.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.